Clover Health Investments, Corp. (CLOV)

NASDAQ • Healthcare

$4.82

+$0.11 (+2.3%)

Market closed

Last close at September 11, 2026 at 20:00 UTC

Open$4.75

Day Range$4.65 - $4.84

Avg. Volume (3M)3.6M

Market Cap$2.4B

52 Week Range

$1.58$5.59

Next EarningsIn 52 daysNov 4, 2026

Metrics Over Time

Where the Money Goes

Q2 2026

Revenueeverything earned$743.1M100%

Gross Profitminus cost of goods$153M21%

Operating Incomeminus R&D and overhead$28M4%

Net Incomeminus taxes and the rest$28M4%

In plain terms: out of every $100 in revenue, Clover Health Investments, Corp. keeps $4 as net profit.

Fundamentals & Financials

Revenue (TTM)

$2.4B

Net Income (TTM)

-$18.3M

EPS (TTM)

-$0.04

ROA (TTM)

-2.55%

Current Ratio

1.5

Dividend Yield

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Income Statement

Balance Sheet

Financial Highlights

Dividends History

Split History

Earnings

-116.7%Q3 2025-$0.02

-350.0%Q4 2025-$0.05

+51.0%Q1 2026-$0.05

0.0%Q2 2026$0.07

+29.4%Q3 2026$0.05

Nov 4

in 52 daysQ4 2026

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

Latest report — Q3 2026

Beat +29.4%

Clover Health Investments’ revenue topped consensus in the second fiscal quarter of 2026, reported August 5, 2026, as revenue rose 56% to roughly $743 million (up from about $478 million a year ago) and came in at $743.2 million versus a $728.3 million estimate (+2%, topped), reflecting growth in its Medicare-focused insurance business across PPO and HMO plan offerings. Profitability tracked with that higher volume, with gross profit of about $153 million and gross margin at roughly 21%. The company generated operating cash flow of about $25 million for the quarter. For the next period, consensus calls for EPS of -$0.00 on revenue of $738.2 million.

View full earnings history

About Clover Health Investments, Corp.

Clover Health Investments, Corp. offers healthcare insurance on the NASDAQ Global Select under ticker CLOV, serving Medicare-eligible members through Preferred Provider Organization (PPO) health plans and Health Maintenance Organization (HMO) health plans. In FY2025, it generated $1.9 billion in revenue.

Name

Clover Health Investments, Corp.

CEO

Andrew Toy

Website

www.cloverhealth.com

Industry

Healthcare

Year Founded

2014

Employees

724

Today's Snapshot

AI-generated

The day ended with CLOV 2.3% higher at 4.82, while its sector was flat. Deutsche Bank, an investment bank, initiated coverage of Clover Health with a Buy rating and a $6 price target.

Trading Volume

Above 10d avg 3.8M

4.4M

vs S&P 500 Today

Outperforming Market

+1.41%

Updated: September 11, 2026 at 20:25 UTC

Technical Indicators

6 Buy1 Neutral1 Sell

Clover’s technicals favor the bulls on balance, supported by strong price positioning above short, medium and long moving averages and momentum readings that show upside bias. RSI is elevated and CCI is strongly positive, while MACD has turned mildly constructive; however, ADX remains low so trend follow‑through is limited. Volatility is moderate with ATR around 4.4%, and on‑balance volume—despite a negative absolute level—registers a buy signal, suggesting buying interest relative to recent flows. The price is above the nearby pivot, but Bollinger measures indicate short‑term stretch. Technical takeaway: buy—broad moving‑average support and positive momentum, though trend strength is modest.

All signals